Forbes Medi-Tech Inc. ("Forbes" or "Company") today announced that Pharmachem Laboratories, Inc. ("Pharmachem") has further increased its revised offer (the "Pharmachem ...
Forbes Medi-Tech Inc. ("Forbes" or "Company") today announced its results for the second quarter ended June 30, 2010. The comparative period for these results is the thr...
Forbes Medi-Tech Inc. ("Forbes" or "Company") today announced that the Pharmachem Laboratories, Inc. ("Pharmachem") revised offer to acquire substantially all of the ass...
Forbes Medi-Tech Inc. ("Forbes" or "Company") today announced that Pharmachem Laboratories, Inc. ("Pharmachem") has offered to acquire substantially all of the assets of...
Forbes Medi-Tech Inc. ("Forbes" or "Company") today announced that MHT, LLC ("MHT") has exercised its "right to match" in respect of the offer of Pharmachem Laboratories...
Forbes Medi-Tech Inc. ("Forbes" or "Company") today announced that Pharmachem Laboratories, Inc. ("Pharmachem"), a U.S.-based manufacturer and supplier of ingredients, i...
Forbes Medi-Tech Inc. ("Forbes" or "Company") today announced that Pharmachem Laboratories, Inc. ("Pharmachem"), a U.S.-based manufacturer and supplier of ingredients, i...
Forbes Medi-Tech Inc. ("Forbes" or "Company") today announced that it has entered into an agreement which will effect the sale of substantially all of its assets (the "A...
The IBTAnnouncement Service helps investors discover the latest information reported by companies in which they are invested, including changes in voting rights, net asset values, and more.